Beyond helping with co-payment assistance for patients with cancer, CancerCare helps with practical and emotional supports for patients, explained Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation.
Beyond helping with co-payment assistance for patients with cancer, CancerCare helps with practical and emotional supports for patients, explained Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation.
Transcript
Beyond financial help, how does CancerCare provide assistance to patients with cancer?
CancerCare is an organization that has been around since 1944. We help with the practical and emotional support that all cancer patients need and even anyone that is affected by the cancer diagnosis. We help with counseling services, we have face-to-face counseling, online counseling, telephone counseling, that we provide free of charge. We also have a lot of educational programs that are provided free-of-charge to the patients and to the providers about different topics. So, it could be about new treatments coming for a specific disease type. It could be about managing the costs of your treatments. Really any topic.
We also provide other financial assistance, non-copayment assistance, which is assistance for transportation because patients with cancer, aside from all these other costs related to diagnosis, they have to go for treatment, maybe it’s once a week, maybe it’s three times a week, if there’s loss of wages because they aren’t able to work full time anymore. Again, we try to help with those practical needs. Transportation, child care, home care, if we could help with a utility bill, we will do that.
In VERIFY, Rusfertide Spares Most Patients With PV a Phlebotomy for 32 Weeks, Improves QOL
June 3rd 2025Adding rusfertide to standard of care more than doubled the share of patients with polycythemia vera (PV) who did not meet criteria for a phlebotomy, according to data from the VERIFY trial.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Depth of Responses, PFS in Transplant-Ineligible Patients Match Overall Findings in CEPHEUS
June 2nd 2025Quadruplet therapy is now the accepted standard for patients newly diagnosed with myeloma who are ineligible for transplant; there is debate whether all newly diagnosed patients should have this regimen.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Multicancer Detection Assays Remain Largely Elusive for Early-Stage Disease Detection
June 1st 2025Multicancer early detection tests are revolutionizing cancer screening by using liquid biopsies to screen for multiple cancers from a single blood sample, enhancing patient outcomes by identifying cancers earlier.
Read More